By Vimal Aga MD (bio) and Rajnish Mago MD (bio) For other articles on this website about lecanemab (Leqembi®), please see Related Pages below. In 2023, the United States Food and Drug Administration (FDA) announced full approval of a treatment for Alzheimer’s disease that is qualitatively different from those that have been available so far…
This content is for Monthly Membership and Yearly Membership members only.
Register
Register
Already a member? Log in here